Company Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.
Equities
600613
CNE000000453
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.61 CNY | -0.30% | -4.20% | -13.14% |
Business Summary
Number of employees: 1,570
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Other
41.8
%
| 965 | 40.4 % | 978 | 41.8 % | +1.35% |
Anti-tumor Drug
30.1
%
| 848 | 35.5 % | 704 | 30.1 % | -16.98% |
Traditional Chinese Medicine Cough Relief
12.5
%
| 219 | 9.2 % | 292 | 12.5 % | +33.77% |
Three High Chronic Disease Product
4.6
%
| 93 | 3.9 % | 107 | 4.6 % | +14.14% |
Skin External Antibacterial
3.8
%
| 101 | 4.2 % | 90 | 3.8 % | -10.82% |
Miao Medicine Muscle and Bone Strengthening
3.8
%
| 82 | 3.4 % | 89 | 3.8 % | +8.33% |
Classic Tonic Product
2.2
%
| 46 | 1.9 % | 50 | 2.2 % | +10.11% |
Magic Baby Medicine
1.3
%
| 35 | 1.5 % | 31 | 1.3 % | -12.32% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 2,389 | 100.0 % | 2,341 | 100.0 % | -2.00% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Bin Feng
CEO | Chief Executive Officer | 52 | 30/06/05 |
Ke Jing Wu
SEC | Corporate Secretary | 47 | 27/04/17 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Bin Feng
CEO | Chief Executive Officer | 52 | 30/06/05 |
Zhi Ting Zhang
BRD | Director/Board Member | 80 | 25/06/20 |
Tao Tao Zhang
CHM | Chairman | 43 | 25/06/14 |
Tao Wu
BRD | Director/Board Member | 52 | 15/10/13 |
Yu Bo Xia
CHM | Chairman | 52 | 25/06/14 |
Dan Xu
BRD | Director/Board Member | 53 | 25/06/14 |
Lan Hu
BRD | Director/Board Member | 55 | 21/06/07 |
Cong Yan Li
BRD | Director/Board Member | 58 | 28/06/20 |
Ke Jing Wu
SEC | Corporate Secretary | 47 | 27/04/17 |
Zhi Mian Chen
DFI | Director of Finance/CFO | 53 | 28/04/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 54,751,650 | 54,751,650 ( 100.00 %) | 0 | 49.01 % |
Stock B | 1 | 479,319,978 | 207,010,338 ( 43.19 %) | 0 |
Company contact information
Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.
Room 613, Changfa Building 128, Weihai Road
200003, Shanghai
+
http://www.gzsq.comSector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-13.14% | 472M | |
+32.36% | 694B | |
+29.67% | 593B | |
-1.60% | 371B | |
+20.07% | 331B | |
+6.04% | 290B | |
+14.64% | 239B | |
+10.22% | 209B | |
-3.27% | 209B | |
+9.27% | 169B |
- Stock Market
- Equities
- 600613 Stock
- Company Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd.